Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05261269
Title A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Dantari, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
UCLA - Parkside Cancer Center Santa Monica California 90404 United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Saint Luke's Cancer Institute Jackson Missouri 64111 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
The University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Magee Women's Hospital Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute/Tennessee Oncology Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field